





Supplementary Information for 
Critical Period After Stroke Study (CPASS): A Phase II Clinical Trial Testing an 
Optimal Time for Motor Recovery After Stroke in Humans 
 
Alexander W. Dromerick1,a,b, Shashwati Geed1,a,b, Jessica Bartha,c, Kathaleen Bradya, Margot Giannettia, 
Abigail Mitchella, Matthew A. Edwardsonb, Ming T. Tanb, Yizhao Zhoub, Elissa L. Newport2b, and Dorothy 
F. Edwardsd 
a MedStar National Rehabilitation Hospital, Washington, DC 20010;  
b Center for Brain Plasticity and Recovery, Department of Rehabilitation Medicine, Georgetown University 
Medical Center, Washington, DC 20057; 
c Washington University School of Medicine, St. Louis MO 63110;  
d University of Wisconsin-Madison School of Medicine and Public Health, Madison WI 53706.  
 
Corresponding Author: 
Elissa L. Newport, Ph.D. 
Center for Brain Plasticity and Recovery  
Georgetown University Medical Center  
4000 Reservoir Rd. NW, Suite 145  
Washington DC 200057 
Email: eln10@georgetown.edu 
Phone: 202-687-6824  
 
This PDF file includes: 
 
Figure S1  
Table S1 
SI References  
  
 
1 A.W.D. and S.G. contributed equally to this work. 





Figure S1. Mean ARAT scores (and standard errors) for each group at baseline, 6month, 12month, pre-








Figure S1. Mean ARAT scores (and standard errors) for each group at baseline, 6month, 12month, pre-
treatment, and post-treatment assessments, shown at the average time at which the assessments 
occurred for the group.  Baseline, 6-month, and 12-month assessments occurred at approximately the 
same time after stroke for all groups. The control group underwent assessments only at these three 
timepoints. However, because the groups differed in when their intervention was administered, each 
group underwent their pre- and post-intervention assessments at different time-points during the study 
period. Baseline and pre-intervention assessment were the same for the acute group; pre-intervention 
and 6-month assessment were the same for the chronic group. The mean ARAT scores (and standard 












































































Supplemental Table S1: Study measures and time points of administration  
Measure Domain Baseline Pretreat Post-Treat 6 Months 
12 
Months 
Primary outcome and randomization 
Action Research Arm Test (1, 2) Motor function limitation (performance) x x x x x 
Age Covariate x     
Oxfordshire classification (3) Covariate (lesion type) x     
Edinburgh Inventory (4) Covariate (handedness) x     
NIH Stroke Scale (5) Stroke severity x x x x x 
Inclusion/exclusion criteria 
Motor Assessment Scale (6) UE Motor functional limitation x     
Manual Muscle Test (7) Muscle strength and function x     
Short Blessed Orientation 
Memory Concentration Test (8) Dementia screen x     
Mesulam Symbol Cancellation 
Test (9) Visuospatial neglect x     
Charlson Comorbidity Index 
(10) 
Covariate (medical 
complexity) x     
Motor (UE) 
Nine-hole Peg Test (11) Motor functional limitation x x x x x 
Fugl-Meyer Upper Arm (12) Motor functional limitation (performance) x    x 
Motricity Index (13) Measure of motor loss x x x x x 
Self-Report 
Motor Activity Log (14) Motor disability (self-report)  x x x x 
Stroke Impact Scale-perception 
of change (15) 
Stroke-specific quality of 
life x x x  x 
Stroke Impact Scale Hand-Arm 
subscale (15) 
Stroke-specific quality of 
life x x x  x 
Handicap and ADL 
Modified Rankin Scale (16) Handicap/Global outcome x (prestroke) x x  x 
Functional Independence 
Measure (17) ADL disability x x x x x 
Barthel Index (18) ADL disability x x x x x 
Participation 
Activity Card Sort (19) Participation  x x x x 
Reintegration to Normal Living 
(20) Participation   x x x 
Other/covariate 
Geriatric Depression Scale (21) Depression screen/covariate x x  x x 
Faces Scale (22) Pain (visual analogue) x x x x x 
Medication Inventory (23) Covariate (recovery-modifying drugs) x x x x x 
 
Table S1 presents the study measures, domain assessed, and timepoint administered. The table is organized to 
present measures first used for randomization and primary outcome, inclusion/exclusion criteria, UE motor 
assessment, self-report, assessment of ADL ability and global handicap, participation and other covariates. 
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